Skip to main content
OpenTrials
Completed

NCT Number: NCT07466264

Contactless Human-Machine-Interface Based on Magnetometers for Consumer Applications

This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. The research aims to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. The results will serve as a foundation for developing future applications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Adult

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Robert Bosch Gmbh, Corporate Sector Research and Advance Engineering

Renningen, Baden-Wurttemberg, 71272, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are at least 18 years of age.
  • Are right-handed with normal or corrected vision.
  • Are employees of Robert Bosch GmbH and are participating in this study during their working hours.
  • They have no acute physical or psychological impairments. They are self-sufficient and have the legal capacity to consent.
  • They have provided written consent to participate in the study and for their data to be processed, and have not withdrawn this consent.

Exclusion criteria

  • Pregnancy
  • Known cardiological, neurological, or psychiatric pre-existing conditions, especially epilepsy, claustrophobia, agoraphobia.
  • Metal-containing prostheses or pacemakers.
  • Inability to lie still for several minutes.
  • Body weight of more than 99 kg.

Treatment and study plan

Magnetoencephalography using quantum-based magnetometers

Device

Detection of extremely weak biomagnetic fields from the brain's neural activity (magnetoencephalography), to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case.

Primary outcomes

  1. Amplitudes of acquired MEG signals

    Time frame: 1 hour

Secondary outcomes

  1. Ratio of MEG signal to ambient noise level

    Time frame: 1 hour

  2. Modulation of magnetic power spectral density

    Time frame: 1 hour

Sponsors and collaborators

Lead sponsor

Robert Bosch GmbH

Industry

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Mar 12, 2026
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.